Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens.

Cantù, M G; Buda, A; Parma, G; Rossi, R; Floriani, I; Bonazzi, C; Dell'Anna, T; Torri, V; Colombo, N

Cantù, M G; Buda, A; Parma, G; Rossi, R; Floriani, I; Bonazzi, C; Dell'Anna, T; Torri, V; Colombo, N.

Affiliation

Cantù MG; Department of Gynaecology Oncology, Università degli Studi di Milano-Bicocca, Ospedale San Gerardo dei Tintori, Monza, Italy.

J Clin Oncol ; 20(5): 1232-7, 2002 Mar 01.

Article in En | MEDLINE | ID: mdl-11870165

Subject(s)

Antineoplastic Agents, Phytogenic/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Ovarian Neoplasms/drug therapy; Paclitaxel/therapeutic use; Adult; Aged; Antineoplastic Agents, Alkylating/administration & dosage; Antineoplastic Agents, Phytogenic/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Drug Hypersensitivity/etiology; Female; Humans; Leukopenia/chemically induced; Middle Aged; Nausea/chemically induced; Neutropenia/chemically induced; Ovarian Neoplasms/mortality; Paclitaxel/adverse effects; Survival Rate; Vomiting/chemically induced

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Antineoplastic Agents, Phytogenic Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2002 Type: Article

Search on Google

XML

PubMed Links